Abstract
Exposure to the endocrine disrupting chemical vinclozolin during gestation of an F0 generation and/or chronic restraint stress during adolescence of the F3 descendants affects behavior, physiology, and gene expression in the brain. Genes related to the networks of growth factors, signaling peptides, and receptors, steroid hormone receptors and enzymes, and epigenetic related factors were measured using quantitative polymerase chain reaction via Taqman low density arrays targeting 48 genes in the central amygdaloid nucleus, medial amygdaloid nucleus, medial preoptic area (mPOA), lateral hypothalamus (LH), and the ventromedial nucleus of the hypothalamus. We found that growth factors are particularly vulnerable to ancestral exposure in the central and medial amygdala; restraint stress during adolescence affected neural growth factors in the medial amygdala. Signaling peptides were affected by both ancestral exposure and stress during adolescence primarily in hypothalamic nuclei. Steroid hormone receptors and enzymes were strongly affected by restraint stress in the mPOA. Epigenetic related genes were affected by stress in the ventromedial nucleus and by both ancestral exposure and stress during adolescence independently in the central amygdala. It is noteworthy that the LH showed no effects of either manipulation. Gene expression is discussed in the context of behavioral and physiological measures previously published.
INTRODUCTION
The amygdala and hypothalamus are heterogeneous and highly interconnected divisions of the limbic system. The amygdala plays a crucial role in memory formation, integration of sensory input, and responses to stressful stimuli (reviewed Sah et al., 2003). In particular, the central amygdaloid nucleus (CeA) is the primary output of the amygdala and is involved in the behavioral and physiological responses of fear and anxiety (). The medial amygdaloid nucleus (MeA) is crucial in appropriate mating behavior and the identification of predators (Lehman and Winans, 1982; Li et al., 2004). The hypothalamus controls pituitary hormone release and much of the body’s physiological function directed by the rest of the brain. The medial preoptic area (mPOA) has been linked to male reproductive behavior and thermoregulation (Liu et al., 1997; Zhang et al., 2011), and the lateral hypothalamus (LH) has been implicated in feeding behavior and some motor aspects of motivation (Lytle and Campbell, 1975). The ventromedial nucleus (VMN) functions in reproductive behavior, feeding, and thermoregulation, and fear responses (; ; ).
The developmental trajectory of an animal is particularly vulnerable to external challenges from gestation through adolescence. Endocrine disrupting chemicals (EDCs) administered early in development affect numerous aspects of physiology and behavior (; ). Vinclozolin is a fungicide and an anti-androgenic EDC that is an effective antagonist of the androgen receptor (Wong et al., 1995). Vinclozolin exposure of males during gestation causes feminizing effects typical of an anti-androgen including reduced anogenital distance, nipple retention, and cleft phallus with hypospadias (Kelce et al., 1994). The effects of gestational exposure to vinclozolin are known to extend for multiple generations. F3 generation males whose F1 progenitors were exposed to vinclozolin during gestation show increased spermatogenic apoptosis, decreased sperm motility, and premature cancer development (,). Exposed F3 males also show behavioral deficits that include aversion by potential mates (), decreased anxiety in aged males (Skinner et al., 2008), and a decreased preference for social novelty ().
The phenotype of an animal is not only a consequence of inheritance but also of an accumulation of the individual’s life experiences. We have previously argued that germline dependent epigenetic modifications, represented in this manuscript by vinclozolin exposure, may influence or interact with context dependent epigenetic modifications (i.e., life experience; ). The current research aims to challenge the phenotype inherited from ancestral vinclozolin exposure with a detrimental life experience. Stress has been well documented to elicit physiological, behavioral, and neurological effects (Padovan and Guimarães, 2000; ; McCormick et al., 2010). Chronic restraint stress is a stressor that is commonly employed in which animals are physically prevented from moving or feeding. Further, adolescence is a particularly vulnerable period of development in which stressful experiences can have long lasting effects (Romeo, 2010). We have previously demonstrated that CRS applied during adolescence reduces anxiety behaviors in adult males (; ).
In this report we mimic a scenario that is more realistic than analyzing a germline and context dependent epigenetic modification in isolation. Vinclozolin exposure three generations previously and chronic restraint stress applied during adolescence were analyzed separately and in combination to determine how the developmental trajectory of the brain was altered. We focus on neural gene expression by qPCR. We find that vinclozolin and CRS primarily affect distinct functional networks of genes and combine to affect expression of methylation machinery in the CeA and thermal regulation in the mPOA. The behavior and physiology of the animals used for these experiments has been previously described () and we discuss the relevance of the current data both in the context of altered behavior, physiology, and the neural networks in which gene expression is altered.
MATERIALS AND METHODS
ANIMALS AND TREATMENT AT F0
Forty eight male Sprague–Dawley rats at ∼120 days of age were used for analysis. All animals were three generations (F3) removed from EDC exposure. F0 gestating dams were injected with either Vinclozolin (100 mg/kg) or DMSO during gestational days 8–14. All breeding was performed within each lineage to yield an F3 generation of pups. No sibling or cousin breeding was allowed. Thus, there were two lineages of animals; one descended from the Vinclozolin and the other from the DMSO treated progenitors. Pups were weaned at postnatal day (PND) 21 and F3 males were shipped from Washington State University to the University of Texas at Austin. Upon arrival, one control lineage and one vinclozolin lineage animal were housed as a pair. Breeding yielded a 4-day variation in age but pairings were restrained to a difference of 1-day. Two cohorts of animals, separated by 4 months, were used for analysis. Each cohort was equally represented in analysis (n = 6 per cohort per group). Cohort was included as a covariant but no differences were found. Pairs were housed in standard polycarbonate rat cages (46 cm × 24 cm × 20.5 cm) on a 14:10 light–dark schedule with ad libitum access to tap water and standard rat chow (rodent chow 5ll2 Prolab RMH 1800 diet, Purina). Environmental enrichment, as per IACUC regulations, was provided to all pairs (7 cm diameter PVC pipe). All animals were removed from their housing for bi-weekly handling and weighing. All animal protocols were reviewed and approved prior to use by the Institutional Animals Care and Used Committee at both the University of Texas at Austin and Washington State University.
CHRONIC RESTRAINT STRESS (CRS) DURING ADOLESCENCE
Half of all pairs were randomly selected for CRS. Both animals in a pair were exposed to CRS for 6 h/day for 21 consecutive days and began at PND 26 and ended PND 46. Pairs were taken together to a separate room 1 h after lights out (9:30 AM) and remained in dark through the duration of restraint. Restraint was applied by gently coaxing each animal into a wire-mesh enclosure (25.4 cm2) that prevented turning and limited limb mobility. Animals were not allowed access to food or water during restraint stress. Binder clips were used to adjust the size of the enclosure as the animals grew. The health of the animals was tracked and considerable efforts were made to ensure that there was no unnecessary pain or discomfort beyond the confines of our approved protocols. Upon completion of the stress paradigm, animal handling and weighing continued until sacrifice at PND 120 (weight data previously published: ). All animals were subjected to a behavioral battery 24-h before sacrifice for which data has already been published ().
EXPERIMENTAL DESIGN
Two experimental manipulations, ancestral vinclozolin exposure, and CRS, yielded a 2 × 2 design resulting in four groups; Control-Non-Stress (C-NS), Control-Stress (C-S), Vinclozolin-Non-Stress (V-NS), and Vinclozolin-Stress (V-S). See Figure 1 for a complete timeline of treatment, stress, and resultant groups.
FIGURE 1
TISSUE COLLECTION
To insure integrity of the RNA, animals were sacrificed via decapitation and the brain removed within 3-min. Brains were chilled on ice for 5-min and sectioned at 2 mm intervals. Five brain areas were extracted for analysis via micropunch (1 mm from Stoelting); mPOA, LH, VMN, medial amygdala (MeA), and central amygdala (CeA). Punches were stored in eppendorf tubes, frozen on dry ice, and stored at -80°C until RNA extraction.
RNA EXTRACTION AND qPCR
RNA was isolated and quantified as previously described (Walker et al., 2013;
Two different TLDA cards were used for analysis. Although there was overlap in many genes, the first targeted genes in the amygdala (MeA and CeA) and the second targeted genes in the hypothalamus (mPOA, LH, and VMH). Each TLDA measured the RNA expression of 48 genes targeted in the categories of epigenetic modification, stress signaling, steroid hormone enzymes, and receptors, neuronal communication, peptides, and receptors, growth factors, and transcription factors. Gene names, abbreviations, and their functional groups are shown in Table 1. Cycle threshold (Ct) was recorded for each sample and mRNA target during the linear phase of PCR. Ct was first normalized (Δ-Ct) to the geometric mean of each individual sample’s expression of rRNA 18s and cell cycle gene Gapdh and was finally normalized (ΔΔ-Ct) to the median expressing animal of the C-NS group for comparison purposes.
Table 1
| Category/Gene | |||
|---|---|---|---|
| Control genes | Glutamatergic | ||
18s | Ribosomal subunit 18s | Gria1 | Glutamate receptor 1 |
Gapdh | Glyceraldehyde-3-phosphate dehydrogenase | Gria2 | Glutamate receptor 2 |
| Epigenetic modification | Grik2 | NMDA (glutamate) receptor ionotropic kainate 2 | |
Dnmt1 | DNA methyltransferase 1 | □Grin1 | NMDA (glutamate) receptor 1 |
Dnmt3a | DNA methyltransferase 3a | □Grin2a | NMDA (glutamate) receptor 2a |
Dnmt3b | DNA methyltransferase 3b | □Grin2b | NMDA (glutamate) receptor 2b |
Dnmt3I | DNA (cytosine-5-)-methyltransferase 3-like | □Grin2c | NMDA (glutamate) receptor 2c |
| ■Hdac1 | Histone deacetylase 1 | □Grin2d | NMDA (glutamate) receptor 1 |
| ■Mbd2 | Methyl-binding domain protein 2 | Peptides and receptors | |
| Stress signaling | Avp | Arginine vasopressin | |
Crh | Corticotropin releasing hormone | Avpr1a | Arginine vasopressin receptor 1A |
| ■Crhr1 | Corticotropin releasing hormone receptor 1 | □Kiss1 | Kisspeptin |
| ■Gmeb2 | Glucocorticoid modulatory element binding protein 2 | □Kiss1r | Kisspeptin receptor (GPR54) |
Nr3c1 | Glucocorticoid receptor | Lepr | Leptin receptor |
Pomc | Proopiomelanocortin | Mc3r | Melanocortin 3 receptor |
| Steroid-hormone enzymes | Mc4r | Melanocortin 4 receptor | |
| □Cyp19a1 | Aromatase | Mc5r | Melanocortin 5 receptor |
| ■Hsd11b2 | Corticosteroid 11-beta dehydrogenase isozyme 2 | Oxt | Oxytocin prepropeptide |
| □Srd5a1 | 5-alpha reductase | Oxtr | Oxytocin receptor |
| Sterod-hormone receptors | □Tac2 | Neurokinin B (tachykinin 3) | |
Ar | Androgen receptor | Growth factors | |
Esr1 | Estrogen receptor alpha | Bdnf | Brain derived neurotrophic factor |
| ■Esr2 | Estrogen receptor beta | ■Ctgf | Connective tissue growth factor |
| ■Gnrhr | Gonadotropin releasing hormone receptor | Igf1 | Insulin-like growth factor 1 |
| □Gper | G protein-coupled receptor 30 (GPR30) | Igf1r | Insulin-like growth factor 1 receptor |
Pgr | Progesterone receptor | ■Igfbp2 | Insulin-like growth factor binding protein 2 |
| Dopaminergic | ■Igfbp5 | Insulin-like growth factor binding protein 5 | |
Comt | Catechol-O-methyltransferase | ■Negr1 | Neuronal growth regulator 1 |
Drd2 | Dopamine receptor D2 | ■Ptgds | Prostaglandin D2 synthase |
Drd4 | Dopamine receptor D4 | ■S100a4 | s100 calcium binding protein A4 |
Th | Tyrosine hydroxylase | Tgfa | Transforming growth factor alpha |
| Serotinergic | Tgfb1 | Transforming growth factor beta 1 | |
| □Slc6a4 | Serotonin transporter (family 6, member 4) | Transcription factors | |
| GABAergic | ■Nfkb1 | Nuclear factor NF-kappa-B | |
| □Gad1 | Glutamate decarboxylase 1 | Nrf1 | Nuclear respiratory factor 1 |
| □Gad2 | Glutamate decarboxylase 2 | Per2 | Period circadian clock 2 |
Gene abbreviations and names.
■Amygdala Only;
Both Areas; □Hypothalamus Only.
Two Taqman Low Density Arrays (TLDA cards, each measuring 48 targeted genes, were used to determine gene expression via qPCR. One card focused on hypothalamic nuclei and the other on amygdaloid nuclei. Gene abbreviations and their full name are shown and are organized by the functional category to which they belong. Genes with a grey box were measured for all nuclei discussed. Genes with a box colored black were measured only in amygdaloid nuclei and genes with a white box were measured only in the hypothalamic nuclei.
STATISTICAL ANALYSIS
Statistical analysis was performed within brain area and within gene product. An analysis of variance (ANOVA) contingency table (2 × 2) was used to examine the main effect of ancestral exposure (vinclozolin versus control), CRS (Stress versus Non-Stress), or the relative contributions of lineage and CRS (Interaction). Normality and homogeneity of variance were determined with a Shapiro–Wilk and Levene’s test, respectively. If the data were determined to be non-normal or have heterogeneous variance a Kruskal–Wallis one-way analysis of variance was used to determine effects of ancestral exposure (vinclozolin versus control lineage) or of CRS (Stress versus Non-Stress). Post hoc pair-wise comparisons were performed using a Mann–Whitney U test.
Finally, in addition to Fisher’s ANOVA, we utilize alternative analytic methods introduced by Hogben. The ANOVA was intended as a formalization of Mendelism and hence is based on the rare phenomenon of traits having a binary nature. Such attempts to deconstruct phenotypic variability using a linear model have consistently proved to have little predictive value (accounting usually for about 5% of the trait). G × E studies as well as more advanced genome-wide association methods are now widely recognized as a failure for understanding complex phenotypes such as disease (
Indeed, our data indicate that the interaction term from ANOVA and synchronicity fundamentally yield different results and are not synonymous. If warranted, the synchronicity comparison can better help the reader discern the source of a statistical effect and elucidate previously hidden ones. Of the 11 genes that showed either an ANOVA interaction effect or synchronicity, only one gene (Mc5r in the mPOA) showed both. This indicates that an ANOVA interaction is not the result of synchronicity but is instead a separate phenomenon.
Post hoc comparisons were only performed against the control C-NS group and only if the group to be compared showed at least a 50% increase or decrease of expression. This strict cutoff resulted in far fewer comparisons than all possible combinations and restricts effects to those with biological significance and robust changes in expression. In the cases that multiple comparisons were performed within a gene, a Benjamini–Hochberg false discovery rate correction was applied and p-values are reported as such. Outliers were removed using Grubb’s test for outlier and consisted of no more than two individuals per group.
RESULTS
CENTRAL AMYGDALOID NUCLEUS (CeA)
Ancestral vinclozolin exposure showed effects in an epigenetic modification gene and two growth factors. The methyl binding protein Mbd2 is thought to be involved the catalyzation of active demethylation and associates with a number of other epigenetic modification proteins. Mbd2 expression was increased due to ancestral vinclozolin exposure (H = 4.08, p = 0.043). The neural proliferation factors Tgfa and Ptgds, which also act as neuromodulators, were affected by vinclozolin exposure and both showed increased expression (H = 6.38, p = 0.012 and H = 6.62, p = 0.01, respectively, Figures 2A,B). Post hoc analysis revealed that expression of Ptgds in V-NS males was significantly higher than C-NS males [W(21) = 29, p = 0.03]. Stress did not significantly affect any of the measured genes in the CeA.
FIGURE 2

Gene expression in the central amygdala. Relative gene expression of Growth factors Tgfa and Ptgds(A,B) show effects of vinclozolin treatment, both up-regulated by ancestral vinclozolin treatment. (C) Epigenetic modification enzyme Dnmt3b shows an interaction with C-S and V-NS up-regulated and V-S near baseline. (D) Stress signaling propeptide Pomc shows a significant interaction with C-S and V-NS animals slightly down-regulated. Lines connecting group bars signify a significant post hoc pair-wise test.
A significant interaction was seen in the epigenetic modification factor Dnmt3b, which catalyzes the de novo addition of methyl groups to CpG dinucleotides [F(1,38) = 10.34, p = 0.003]. This interaction is the result of increased Dnmt3b expression in C-S and V-NS animals but not V-S animals (Figure 2C). C-S animals showed a 49% increase in expression of Dnmt3b but did not meet the threshold for statistical comparison. The stress signaling pro-peptide Pomc was found to show an interaction of stress and lineage [F(1,37) = 6.19, p = 0.018, Figure 2D] and was due to a significant decrease of expression in V-NS animals and a non-significant increase V-S animals as identified by post hoc-analysis [W(20) = 100, p = 0.01]. Post hoc comparison of C-NS versus V-S (synchronicity) indicates increased expression of Ptgds [W(21) = 30, p = 0.03]. A summary of the data and significant effects identified in the CeA are listed in Table 2A.
Table 2
| Gene | Treatment | Stress | N | Mean ± SEM | Effects/synch |
|---|---|---|---|---|---|
| (A) CeA | |||||
| Dnmt3b | Control | Non-Stress | 10 | 0.98 ± 0.16 | Interaction |
| Stress | 10 | 1.47 ± 0.11 | |||
| Vinclozolin | Non-Stress | 12 | 1.30 ± 0.18 | ||
| Stress | 10 | 0.85 ± 0.10 | |||
| Mbd2 | Control | Non-Stress | 11 | 1.13 ± 0.11 | Effect of lineage |
| Stress | 11 | 1.32 ± 0.21 | |||
| Vinclozolin | Non-Stress | 11 | 1.33 ± 0.12 | ||
| Stress | 12 | 1.42 ± 0.10 | |||
| Pomc | Control | Non-Stress | 11 | 1.00 ± 0.102 | Interaction |
| Stress | 8 | 0.86 ± 0.24 | |||
| Vinclozolin | Non-Stress | 11 | 0.60 ± 0.082 | ||
| Stress | 11 | 1.18 ± 0.16 | |||
| Ptgds | Control | Non-Stress | 11 | 1.14 ± 0.182 | Effect of lineage/synchronicity |
| Stress | 11 | 1.37 ± 0.222 | |||
| Vinclozolin | Non-Stress | 12 | 2.10 ± 0.38 | ||
| Stress | 12 | 2.27 ± 0.41 | |||
| Tgfa | Control | Non-Stress | 12 | 0.96 ± 0.12 | Effect of lineage |
| Stress | 9 | 0.91 ± 0.10 | |||
| Vinclozolin | Non-Stress | 12 | 1.42 ± 0.15 | ||
| Stress | 11 | 1.18 ± 0.13 | |||
| (B) MeA | |||||
| Ctgf | Control | Non-Stress | 10 | 1.07 ± 0.171 | Effect of stress/synchronicity |
| Stress | 10 | 1.68 ± 0.221 | |||
| Vinclozolin | Non-Stress | 10 | 1.13 ± 0.15 | ||
| Stress | 11 | 1.89 ± 0.29 | |||
| Per2 | Control | Non-Stress | 10 | 1.16 ± 0.17 | Effect of lineage |
| Stress | 10 | 1.41 ± 0.20 | |||
| Vinclozolin | Non-Stress | 10 | 0.93 ± 0.16 | ||
| Stress | 10 | 0.96 ± 0.10 | |||
| Ptgds | Control | Non-Stress | 9 | 1.06 ± 0.18 | Effect of lineage |
| Stress | 10 | 1.18 ± 0.26 | |||
| Vinclozolin | Non-Stress | 11 | 1.70 ± 0.30 | ||
| Stress | 11 | 2.17 ± 0.66 | |||
| Tgfa | Control | Non-Stress | 8 | 1.15 ± 0.191,2 | Effect of stress/synchronicity |
| Stress | 9 | 2.07 ± 0.331 | |||
| Vinclozolin | Non-Stress | 9 | 1.62 ± 0.282 | ||
| Stress | 10 | 1.83 ± 0.24 |
Amygdala data summary.
The mean, SE of the mean, group N, main effects or interactions, and post hoc effects are summarized for the (A) central amygdaloid nucleus and (B) medial amygdaloid nucleus. All post hoc comparisons are relative to the control Non-Stress group (C-NS). 1Indicates a change of expression in C-S animals and 2in V-NS animals. Main effects, interactions, and effects of synchronicity (C-NS vs V-S) are listed within the appropriate gene.
MEDIAL AMYGDALOID NUCLEUS (MeA)
Ancestral vinclozolin exposure was found to affect two genes in the MeA. Growth gene and neural modulator Ptgds was increased (H = 5.17, p = 0.023, Figure 3A). Per2, which contains a glucocorticoid response element and modulates glucocorticoid-mediate gene expression, was decreased due to ancestral exposure to vinclozolin (H = 4.01, p = 0.045, Figure 3B). The MeA showed neural proliferation genes were particularly affected by stress. CRS increased the expression of two growth factors in the MeA, Ctgf and Tgfa (H = 8.38, p = 0.004 and H = 4.58, p = 0.032, respectively, Figures 3C,D). Post hoc analysis of Ctgf revealed that C-S animals had a substantial increase in expression of Ctgf [W(18) = 23, p = 0.04, Figure 3C]. Post hoc analysis was similar for Tgfa in C-S animals [W(13) = 3, p < 0.01, Figure 3D]. A significant increase in V-NS animals was also identified [W(15) = 11, p = 0.02].
FIGURE 3

Gene expression in the medial amygdala. Relative gene expression of (A) Growth factor and neuromodulator Ptgds shows a significant effect of ancestral vinclozolin exposure. (B) Circadian rhythm gene Per2 was significantly down regulated by ancestral vinclozolin exposure. (C,D) Growth factors Ctgf and Tgfa show effects of CRS, both up-regulated by CRS during adolescence. Post hoc Ctgf comparisons of C-S and V-S were significantly increased compared to C-NS. All three treatment groups (C-S, V-NS, and V-S) were found to be significantly increased in post hoc analysis of Tgfa. Lines connecting group bars signify a significant post hoc pair-wise test.
No significant interactions were identified in the MeA. Post hoc comparisons of synchronicity revealed increased expression of two growth factors, Ctgf, and Tgfa [W(20) = 20, p = 0.04 and W(15) = 11, p = 0.02, respectively, Figure 5B]. A summary of the data and significant effects identified in the MeA are listed in Table 2B.
MEDIAL PREOPTIC AREA (mPOA)
The mPOA was particularly vulnerable to both CRS and vinclozolin exposure compared to the other hypothalamic nuclei analyzed. Both vinclozolin exposure and CRS affected steroid hormone genes and metabolic related genes in the mPOA. Vinclozolin exposure decreased the expression of Ar (H = 6.14, p = 0.013) an effect driven largely by the substantial decrease of expression in V-NS animals [W(20) = 96, p = 0.02, Figure 4A]. Lepr expression appears to be decreased due to vinclozolin exposure [F(1,37) = 4.73, p = 0.036] but post hoc analysis reveals that this effect is driven by the increase of expression in C-S animals [W(18) = 18, p = 0.02, Figure 4B]. Post hoc analysis revealed that the Igf1 growth factor ligand was revealed to have increased expression in V-NS animals [W(19) = 21, p = 0.04]. CRS increased the expression of aromatase (Cyp19a1), which catalyzes the conversion of androgens to estrogens, and the estrogen receptor Esr1 (H = 5.37, p = 0.021 and H = 5.97, p = 0.015, respectively, Figures 4C,D). CRS also increased the expression of two peptide receptors, the leptin receptor Lepr and melanocortin receptor Mc4r [F(1,37) = 7.46, p = 0.010, Figure 4B and F(1,38) = 4.13, p = 0.049, respectively]. The circadian regulation gene Per2 was found to be slightly but significantly increased due to CRS (H = 5.27, p = 0.022).
FIGURE 4

Gene expression in the medial preoptic area (mPOA). Relative gene expression of (A) Steroid hormone receptor Ar, which shows a decrease of expression due to ancestral exposure. (B) Peptide receptor Lepr shows an effect of vinclozolin treatment, an effect driven by the large increase in expression in C-S animals. (C,D) Steroid synthesis enzyme Cyp19a1 (aromatase) and steroid hormone receptor Esr1 are both up-regulated by CRS. (E) Peptide receptor Mc5r shows an effect of vinclozolin exposure. Expression in C-S animals is also increased. Lines connecting group bars signify a significant post hoc pair-wise test.
A significant interaction in Mc5r expression resulted from the combination of CRS and vinclozolin exposure [F(1,30) = 5.36, p = 0.028] that is driven by an increase of expression in C-S and V-NS animals [W(13) = 4, p < 0.01 and W(17) = 16, p = 0.02, respectively, Figure 4E]. Post hoc comparisons of synchronicity showed that Mc5r expression was increased in V-S animals [W(14) = 13, p = 0.02, Figure 4E]. A summary of the data and significant effects identified in the mPOA are listed in Table 3A.
Table 3
| Gene | Treatment | Stress | N | Mean ± SEM | Effects/synch |
|---|---|---|---|---|---|
| (A) mPOA | |||||
| Ar | Control | Non-Stress | 11 | 0.96 ± 0.112 | Effect of lineage |
| Stress | 10 | 1.31 ± 0.23 | |||
| Vinclozolin | Non-Stress | 11 | 0.61 ± 0.062 | ||
| Stress | 10 | 0.89 ± 0.14 | |||
| Cyp19a1 | Control | Non-Stress | 11 | 1.31 ± 0.341 | Effect of stress |
| Stress | 10 | 2.99 ± 1.141 | |||
| Vinclozolin | Non-Stress | 11 | 0.74 ± 0.16 | ||
| Stress | 10 | 1.93 ± 0.57 | |||
| Esr1 | Control | Non-Stress | 11 | 1.25 ± 0.18 | Effect of stress |
| Stress | 10 | 2.46 ± 0.65 | |||
| Vinclozolin | Non-Stress | 11 | 0.93 ± 0.17 | ||
| Stress | 10 | 2.03 ± 0.49 | |||
| Igf1 | Control | Non-Stress | 10 | 1.03 ± 0.102 | No effect |
| Stress | 10 | 1.69 ± 0.31 | |||
| Vinclozolin | Non-Stress | 11 | 1.64 ± 0.212 | ||
| Stress | 10 | 1.31 ± 0.22 | |||
| Lepr | Control | Non-Stress | 10 | 1.00 ± 0.10 | Effect of lineage and stress |
| Stress | 10 | 1.51 ± 0.15 | |||
| Vinclozolin | Non-Stress | 11 | 0.90 ± 0.10 | ||
| Stress | 10 | 1.08 ± 0.15 | |||
| (B) VMN | |||||
| Dnmt3b | Control | Non-Stress | 12 | 1.12 ± 0.152 | Effect of lineage/synchronicity |
| Stress | 8 | 0.92 ± 0.09 | |||
| Vinclozolin | Non-Stress | 11 | 0.58 ± 0.082 | ||
| Stress | 11 | 0.60 ± 0.13 | |||
| Grin2d | Control | Non-Stress | 11 | 0.98 ± 0.111 | Interaction |
| Stress | 9 | 1.56 ± 0.201 | |||
| Vinclozolin | Non-Stress | 12 | 1.33 ± 0.16 | ||
| Stress | 12 | 1.25 ± 0.15 | |||
| Igf1r | Control | Non-Stress | 12 | 1.03 ± 0.06 | Interaction |
| Stress | 9 | 1.17 ± 0.07 | |||
| Vinclozolin | Non-Stress | 12 | 1.13 ± 0.04 | ||
| Stress | 11 | 0.97 ± 0.05 | |||
| Mc5r | Control | Non-Stress | 7 | 0.86 ± 0.11 | Synchronicity |
| Stress | 7 | 1.06 ± 0.17 | |||
| Vinclozolin | Non-Stress | 10 | 1.33 ± 0.25 | ||
| Stress | 11 | 1.42 ± 0.18 |
Hypothalamus data summary.
The mean, SE of the mean, group N, main effects or interactions, and post hoc effects are summarized for (A) the mPOA and (B) ventromedial nucleus. All post hoc comparisons are relative to the C-NS group. 1indicates a change of expression in C-S animals and 2in V-NS animals. Main effects, interactions, and effects of synchronicity (C-NS vs. V-S) are listed within the appropriate gene.
LATERAL HYPOTHALAMUS (LH)
There were no main effects of CRS, ancestral vinclozolin exposure, or interactions of gene expression in the LH. Similarly, post hoc analysis did not identify any significant pair-wise changes in gene expression.
VENTROMEDIAL NUCLEUS (VMN)
Ancestral vinclozolin exposure substantially reduced the expression of the epigenetic modifier Dnmt3b [F(1,38) = 13.86, p = 0.001]. Post hoc analysis revealed that V-NS animals showed reduced expression of Dnmt3b [W(21) = 109, p = 0.02, Figure 5A]. No main effects or post hoc effects due to CRS were identified. A significant interaction of CRS and vinclozolin exposure was identified for glutamate receptor subunit Grin2d [F(1,40) = 4.56, p = 0.041] which in large part was driven by a significant increase identified by post hoc analysis in C-S animals [W(18) = 19, p = 0.02].
FIGURE 5

Gene expression in the ventromedial nucleus (VMN). Relative gene expression of (A) Epigenetic modification enzyme Dnmt3b which shows a significant decrease of expression due to ancestral vinclozolin exposure. (B) Peptide receptor Mc5r shows a significant expression increase in V-S animals. Lines connecting group bars signify a significant post hoc pair-wise test.
A significant interaction was evident in growth factor Igf1r although changes in individual group expression are minimal [F(1,40) = 8.27, p = 0.006]. Post hoc comparisons of synchronicity showed that V-S animals had reduced Dnmt3b expression and [W(21) = 101, p = 0.03, Figure 5A]. Synchronicity was also present in the melanocortin receptor Mc5r of V-S animals, which plays an integral role in energy homeostasis and feeding behavior [W(16) = 16, p = 0.05, Figure 5B]. A summary of the data and significant effects identified in the VMN are listed in Table 3B.
DISCUSSION
The amygdala and hypothalamus integrate incoming sensory information, monitor the internal state, and provide appropriate behavioral and physiological response. Insults to the delicate milieu of gene expression of neurons within these areas can ultimately manifest as altered, and sometimes inappropriate, behavior. We have previously shown that both behavior and physiology in adulthood is altered due to vinclozolin exposure three generations previously and CRS experienced during adolescence (
GROWTH FACTORS AND THE AMYGDALA
Growth factors play a crucial role in forming and remodeling neurons and their connections in the brain. Neural growth factors alter firing frequency and direct the axonal and dendritic extensions of the neurons to provide additional and appropriate connections to its neighboring and distant targets (McAllister et al., 1999; Singh et al., 2006;
Following CRS exposure the firing activity of neurons and dendritic arborization in the amygdala is altered (Vyas et al., 2002; Zhang and Rosenkranz, 2012) and plasticity is affected (
EPIGENETIC MODIFICATION FACTORS
DNA methylation has been most thoroughly considered for its role in cellular differentiation and considered to be a static process. We now know that DNA methylation and demethylation are highly dynamic processes that are necessary for proper cognitive function (Miller and Sweatt, 2007; Sultan et al., 2012). Mbd2 is a protein cofactor that has been linked to demethylation activity and transcriptional activation in vivo and in vitro although it does not itself contain catalytic activity (
STEROID RECEPTORS IN THE mPOA
The mPOA is essential for male copulatory behaviors. Lesions to the mPOA and inhibition of the androgen receptor negatively affect a male rats’ ability to successfully copulate (Liu et al., 1997;
THERMOREGULATORY FACTORS IN THE mPOA
Endocrine disrupting chemicals can influence body weight and produce obesity phenotypes, regardless of their target steroid receptor molecule (Newbold et al., 2005) and can transcend multiple generations after initial exposure (Manikkam et al., 2013). Previous work in our lab suggests that ancestral treatment of vinclozolin results in increased body weight throughout life (
CONCLUSION
Both germline- and context-dependent epigenetic modifications can influence the physiology and behavior of an animal. Ancestral vinclozolin exposure and CRS are examples of those epigenetic modifications and have both been shown to produce modified phenotypes. The current data provide insight into how these affects may manifest. Germline- and context-dependent modifications have the ability to interact in a number of ways to influence the phenotype; additively, synergistically, or independently. Our data suggest that ancestral vinclozolin exposure and CRS independently influence the phenotype and interact at the level of DNA methylation machinery, a broad and likely point of interaction.
Statements
Acknowledgments
This work supported by NSF (to RG), NIH ES012974 (MKS), and NIH ES017538 and ES023254 (DC).
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
REFERENCES
1
AnwayM. D.LeathersC.SkinnerM. K. (2006a). Endocrine disruptor vinclozolin induced epigenetic transgenerational adult-onset disease.Endocrinology1475515–5523. 10.1210/en.2006-0640
2
AnwayM. D.MemonM. A.UzumcuM.SkinnerM. K. (2006b). Transgenerational effect of the endocrine disruptor vinclozolin on male spermatogenesis.J. Androl.27868–879. 10.2164/jandrol.106.000349
3
BlessingW.MohammedM.OotsukaY. (2012). Heating and eating: brown adipose tissue thermogenesis precedes food ingestion as part of the ultradian basic rest–activity cycle in rats.Physiol. Behav.105966–974. 10.1016/j.physbeh.2011.11.009
4
BurrowsR. C.LevittP.ShorsT. J. (2000). Postnatal decrease in transforming growth factor alpha is associated with enlarged ventricles, deficient amygdaloid vasculature and performance deficits.Neuroscience96825–836. 10.1016/S0306-4522(99)00558-8
5
CohenR. S.PfaffD. W. (1992). Ventromedial hypothalamic neurons in the mediation of long-lasting effects of estrogen on lordosis behavior.Prog. Neurobiol.38423–453. 10.1016/0301-0082(92)90045-G
6
CorderoM. I.RodríguezJ. J.DaviesH. A.PeddieC. J.SandiC.StewartM. G. (2005). Chronic restraint stress down-regulates amygdaloid expression of polysialylated neural cell adhesion molecule.Neuroscience133903–910. 10.1016/j.neuroscience.2005.03.046
7
CrewsD. (2011). Epigenetic modifications of brain and behavior: theory and practice.Horm. Behav.59393–398. 10.1016/j.yhbeh.2010.07.001
8
CrewsD.GilletteR.Miller-CrewsI.GoreA. C.SkinnerM. K. (2014). Nature, nurture and epigenetics.Mol. Cell. Endocrinol.39842–52. 10.1016/j.mce.2014.07.013
9
CrewsD.GilletteR.ScarpinoS. V.ManikkamM.SavenkovaM. I.SkinnerM. K. (2012). Epigenetic transgenerational inheritance of altered stress responses. Proc. Natl. Acad. Sci.U.S.A.1099143–9148. 10.1073/pnas.1118514109
10
CrewsD.GoreA. C. (2012). Epigenetic synthesis: a need for a new paradigm for evolution in a contaminated world.F1000 Biol. Rep.418. 10.3410/B4-18
11
CrewsD.GoreA. C.HsuT. S.DanglebenN. L.SpinettaM.SchallertT.et al (2007). Transgenerational epigenetic imprints on mate preference.Proc. Natl. Acad. Sci. U.S.A.1045942–5946. 10.1073/pnas.0610410104
12
DavisM. (1992). The role of the amygdala in fear and anxiety.Annu. Rev. Neurosci.15353–375. 10.1146/annurev.ne.15.030192.002033
13
Davis-López de CarrizosaM. A.Morado-DíazC. J.MorcuendeS.de la CruzR. R.PastorA. M. (2010). Nerve growth factor regulates the firing patterns and synaptic composition of motoneurons.J. Neurosci.308308–8319. 10.1523/jneurosci.0719-10.2010
14
Diamanti-KandarakisE.BourguignonJ.-P.GiudiceL. C.HauserR.PrinsG. S.SotoA. M.et al (2009). Endocrine-disrupting chemicals: an endocrine society scientific statement.Endocr. Rev.30293–342. 10.1210/er.2009-2002
15
EgawaM.InoueS.SatoS.TakamuraY.MurakamiN.TakahashiK. (1991). Restoration of circadian corticosterone rhythm in ventromedial hypothalamic lesioned rats.Neuroendocrinology53543–548. 10.1159/000125772
16
EguchiN.MinamiT.ShirafujiN.KanaokaY.TanakaT.NagataA.et al (1999). Lack of tactile pain (allodynia) in lipocalin-type prostaglandin D synthase-deficient mice.Proc. Natl. Acad. Sci. U.S.A.96726–730. 10.1073/pnas.96.2.726
17
FlierJ. S.Maratos-FlierE. (1998). Obesity and the hypothalamus: novel peptides for new pathways.Cell92437–440. 10.1016/S0092-8674(00)80937-X
18
GilletteR.Miller-CrewsI.NilssonE. E.SkinnerM. K.GoreA. C.CrewsD. (2014). Sexually dimorphic effects of ancestral exposure to vinclozolin on stress reactivity in rats.Endocrinology1553853–3866. 10.1210/en.2014-1253
19
HardingS. M.McGinnisM. Y. (2004). Androgen receptor blockade in the MPOA or VMN: effects on male sociosexual behaviors.Physiol. Behav.81671–680. 10.1016/j.physbeh.2004.03.008
20
HendrichB.BirdA. (1998). Identification and characterization of a family of mammalian methyl-CpG binding proteins.Mol. Cell. Biol.186538–6547.
21
HogbenL. (1932). Genetic Principles in Medicine and Social Sciences.New York, NY: Alfred A. Knopf.
22
HwaJ. J.GhibaudiL.GaoJ.ParkerE. M. (2001). Central melanocortin system modulates energy intake and expenditure of obese and lean zucker rats.Am. J. Physiol. Regul. Integr. Comp. Physiol.281R444–R451.
23
IsgorC.KabbajM.AkilH.WatsonS. J. (2004). Delayed effects of chronic variable stress during peripubertal-juvenile period on hippocampal morphology and on cognitive and stress axis functions in rats.Hippocampus14636–648. 10.1002/hipo.10207
24
KelceW. R.MonossonE.GamcsikM. P.LawsS. C.GrayL. E. (1994). Environmental hormone disruptors: evidence that vinclozolin developmental toxicity is mediated by antiandrogenic metabolites.Toxicol. Appl. Pharmacol.126276–285. 10.1006/taap.1994.1117
25
KishiT.AschkenasiC. J.LeeC. E.MountjoyK. G.SaperC. B.ElmquistJ. K. (2003). Expression of melanocortin 4 receptor mRNA in the central nervous system of the rat.J. Comp. Neurol.457213–235. 10.1002/cne.10454
26
KuzawaC. (2012). Why evolution needs development, and medicine needs evolution.Int. J. Epidemiol.41223–229. 10.1093/ije/dys005
27
LehmanM. N.WinansS. S. (1982). Vomeronasal and olfactory pathways to the amygdala controlling male hamster sexual behavior: autoradiographic and behavioral analyses.Brain Res.24027–41. 10.1016/0006-8993(82)90641-2
28
LiC.-I.MaglinaoT. L.TakahashiL. K. (2004). Medial amygdala modulation of predator Odor-Induced unconditioned fear in the rat.Behav. Neurosci.118324–332. 10.1037/0735-7044.118.2.324
29
LiE.BeardC.JaenischR. (1993). Role for DNA methylation in genomic imprinting.Nature366362–365. 10.1038/366362a0
30
LiuY.LiuZ.LiX.LuoB.XiongJ.GanW.et al (2014). Accumulation of connective tissue growth factor+ cells during the early phase of rat traumatic brain injury.Diagn. Pathol.9141. 10.1186/1746-1596-9-141
31
LiuY. C.SalamoneJ. D.SachsB. D. (1997). Lesions in medial preoptic area and bed nucleus of stria terminalis: differential effects on copulatory behavior and noncontact erection in male rats.J. Neurosci.175245–5253.
32
LytleL. D.CampbellB. A. (1975). Effects of lateral hypothalamic lesions on consummatory behavior in developing rats.Physiol. Behav.15323–331. 10.1016/0031-9384(75)90100-6
33
ManikkamM.TraceyR.Guerrero-BosagnaC.SkinnerM. K. (2013). Plastics derived endocrine disruptors (BPA, DEHP and DBP) induce epigenetic transgenerational inheritance of obesity, reproductive disease and sperm epimutations.PLoS ONE8:e55387. 10.1371/journal.pone.0055387
34
McAllisterA. K.KatzL. C.LoD. C. (1999). Neurotrophins and synaptic plasticity.Annu. Rev. Neurosci.22295–318. 10.1146/annurev.neuro.22.1.295
35
McCormickC. M.MathewsI. Z.ThomasC.WatersP. (2010). Investigations of HPA function and the enduring consequences of stressors in adolescence in animal models.Brain Cogn.7273–85. 10.1016/j.bandc.2009.06.003
36
MillerC. A.SweattJ. D. (2007). Covalent modification of DNA regulates memory formation.Neuron53857–869. 10.1016/j.neuron.2007.02.022
37
MohriI.EguchiN.SuzukiK.UradeY.TaniikeM. (2003). Hematopoietic prostaglandin D synthase is expressed in microglia in the developing postnatal mouse brain.Glia42263–274. 10.1002/glia.10183
38
NewboldR. R.Padilla-BanksE.SnyderR. J.JeffersonW. N. (2005). Developmental exposure to estrogenic compounds and obesity.Birth Defects Res. Part A Clin. Mol. Teratol.73478–480. 10.1002/bdra.20147
39
OkanoM.BellD. W.HaberD. A.LiE. (1999). DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development.Cell99247–257. 10.1016/S0092-8674(00)81656-6
40
PadovanC. M.GuimarãesF. S. (2000). Restraint-induced hypoactivity in an elevated plus-maze.Braz. J. Med. Biol. Res.3379–83. 10.1590/S0100-879X2000000100011
41
PaisleyJ. C.HuddlestonG. G.CarruthL. L.PetrulisA.GroberM. S.ClancyA. N. (2012). Sexual responses of the male rat medial preoptic area and medial amygdala to estrogen I: site specific suppression of estrogen receptor alpha.Horm. Behav.6250–57. 10.1016/j.yhbeh.2012.04.018
42
RockmanM. V. (2012). The QTN program and the alleles that matter for evolution: all that’s gold does not glitter.Evolution (N. Y.)661–17. 10.1111/j.1558-5646.2011.01486.x
43
RomeoR. D. (2010). Adolescence: a central event in shaping stress reactivity.Dev. Psychobiol.52244–253. 10.1002/dev.20437
44
SahP.FaberE. S. L.Lopez De ArmentiaM.PowerJ. (2003). The amygdaloid complex: anatomy and physiology.Physiol. Rev.83803–834. 10.1152/physrev.00002.2003
45
SinghB.HennebergerC.BetancesD.ArevaloM. A.Rodríguez-TébarA.MeierJ. C.et al (2006). Altered balance of glutamatergic/GABAergic synaptic input and associated changes in dendrite morphology after BDNF expression in BDNF-deficient hippocampal neurons.J. Neurosci.267189–7200. 10.1523/JNEUROSCI.5474-05.2006
46
SkinnerM. K.AnwayM. D.SavenkovaM. I.GoreA. C.CrewsD. (2008). Transgenerational epigenetic programming of the brain transcriptome and anxiety behavior.PLoS ONE3:e3745. 10.1371/journal.pone.0003745
47
SultanF. A.WangJ.TrontJ.LiebermannD. A.SweattJ. D. (2012). Genetic deletion of gadd45b, a regulator of active DNA demethylation, enhances long-term memory and synaptic plasticity.J. Neurosci.3217059–17066. 10.1523/JNEUROSCI.1747-12.2012
48
UeberhamU.UeberhamE.GruschkaH.ArendtT. (2003). Connective tissue growth factor in Alzheimer’s disease.Neurosci.1161–6. 10.1016/S0306-4522(02)00670-X
49
VyasA.MitraR.Shankaranarayana RaoB. S.ChattarjiS. (2002). Chronic stress induces contrasting patterns of dendritic remodeling in hippocampal and amygdaloid neurons.J. Neurosci.226810–6818.
50
WalkerD. M.KermathB. A.WollerM. J.GoreA. C. (2013). Disruption of reproductive aging in female and male rats by gestational exposure to estrogenic endocrine disruptors.Endocrinology1542129–2143. 10.1210/en.2012–2123
51
WangL.LiuY.HanR.BeierU. H.ThomasR. M.WellsA. D.et al (2013). Mbd2 promotes foxp3 demethylation and T-regulatory-cell function.Mol. Cell. Biol.334106–4115. 10.1128/MCB.00144-13
52
WongC.KelceW. R.SarM.WilsonE. M. (1995). Androgen receptor antagonist versus agonist activities of the fungicide vinclozolin relative to hydroxyflutamide.J. Biol. Chem.27019998–20003. 10.1074/jbc.270.34.19998
53
YamashitaA.WatanabeY.HayaishiO. (1983). Autoradiographic localization of a binding protein(s) specific for prostaglandin D2 in rat brain.Proc. Natl. Acad. Sci. U.S.A.806114–6118. 10.1073/pnas.80.19.6114
54
ZhangW.RosenkranzJ. A. (2012). Repeated restraint stress increases basolateral amygdala neuronal activity in an age-dependent manner.Neurosci.226459–474. 10.1016/j.neuroscience.2012.08.051
55
ZhangY.KermanI. A.LaqueA.NguyenP.FaouziM.LouisG. W.et al (2011). Leptin-receptor-expressing neurons in the dorsomedial hypothalamus and median preoptic area regulate sympathetic brown adipose tissue circuits.J. Neurosci.311873–1884. 10.1523/jneurosci.3223-10.2011
Summary
Keywords
endocrine disruption, amygdala, hypothalamus, transgenerational, vinclozolin
Citation
Gillette R, Miller-Crews I, Skinner MK and Crews D (2015) Distinct actions of ancestral vinclozolin and juvenile stress on neural gene expression in the male rat. Front. Genet. 6:56. doi: 10.3389/fgene.2015.00056
Received
21 December 2014
Accepted
06 February 2015
Published
02 March 2015
Volume
6 - 2015
Edited by
Douglas Mark Ruden, Wayne State University, USA
Reviewed by
Eberhard Weihe, University of Marburg, Germany; Alice Hudder, Lake Erie College of Osteopathic Medicine, USA
Copyright
© 2015 Gillette, Miller-Crews, Skinner and Crews.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: David Crews, Department of Integrative Biology, The University of Texas at Austin, 2405 Speedway, Austin, TX 78712, USA e-mail: crews@mail.utexas.edu
This article was submitted to Toxicogenomics, a section of the journal Frontiers in Genetics.
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.